
Sign up to save your podcasts
Or


We discuss a study on the use of the mu-opioid receptor antagonist, samidorphan for olanzapine-induced weight gain, compared to placebo and naltrexone.
By Psychopharmacology Institute4.6
269269 ratings
We discuss a study on the use of the mu-opioid receptor antagonist, samidorphan for olanzapine-induced weight gain, compared to placebo and naltrexone.

700 Listeners

75 Listeners

497 Listeners

147 Listeners

302 Listeners

3,343 Listeners

158 Listeners

1,353 Listeners

712 Listeners

558 Listeners

472 Listeners

371 Listeners

715 Listeners

190 Listeners

154 Listeners